Table 4.

Associations between Cardiometabolic Risk Factors and Electrocardiographic Left Ventricular Hypertrophy in Men.

	Sokolow-Lyon based ECG-LVH				Cornell based ECG-LVH
	Model 1		Model 2		Model 1		Model 2
	OR (95% CI)	p-value	OR (95% CI)	p-value	OR (95% CI)	p-value	OR (95% CI)	p-value
BP ≥ 130/85 mmHg	1.26 (1.01–1.57)	0.04	1.28 (1.03–1.60)	0.03	1.66 (1.19–2.30)	< 0.01	1.65 (1.19–2.29)	< 0.01
Total cholesterol ≥ 200 mg/dl	0.87 (0.70–1.10)	0.24	0.87 (0.70–1.10)	0.24	0.95 (0.65–1.37)	0.76	0.95 (0.65–1.37)	0.76
HDL-C < 40 mg/dl	0.82 (0.65–1.03)	0.09	0.84 (0.67–1.06)	0.13	0.91 (0.62–1.33)	0.62	0.90 (0.61–1.32)	0.58
Serum triglycerides ≥ 150 mg/dl	1.00 (0.79–1.27)	0.98	1.02 (0.80–1.29)	0.89	1.44 (1.01–2.05)	0.04	1.44 (1.01–2.04)	0.04
Fasting glucose ≥ 100 mg/dl	0.83 (0.66–1.05)	0.12	0.84 (0.67–1.06)	0.13	0.89 (0.61–1.31)	0.55	0.89 (0.61–1.31)	0.55
Serum uric acid ≥ 7.0 mg/dl	0.83 (0.69–1.00)	0.05	0.84 (0.70–1.01)	0.07	1.03 (0.76–1.39)	0.87	1.02 (0.75–1.38)	0.90
Waist circumference ≥ 90 mg/dl	0.52 (0.43–0.65)	< 0.01	0.54 (0.43–0.66)	< 0.01	1.26 (0.91–1.74)	0.16	1.25 (0.90–1.73)	0.18
Metabolic syndrome	0.71 (0.54–0.94)	0.01	0.74 (0.56–0.97)	0.03	1.29 (0.86–1.95)	0.22	1.28 (0.85–1.93)	0.24

Multiple logistic regressions were used to determine the association of cardiometabolic risk factors with electrocardiographic LVH.

Model 1 adjusted for age, BP ≥ 130/85 mmHg, total cholesterol ≥ 200 mg/dl, HDL-C < 40 mg/dl, serum triglycerides ≥ 150 mg/dl, fasting glucose ≥ 100 mg/dl, serum uric acid ≥ 7.0 mg/dl, waist circumference ≥ 90 mg/dl, metabolic syndrome status, cigarette smoking status and alcohol intake status.

Model 2 adjusted for the covariates in model 1 and 3000-m running time.

BP Blood pressure, HDL-C High-density lipoprotein cholesterol, LVH Left ventricular hypertrophy.